Juarez M, Schcolnik-Cabrera A, Dominguez-Gomez G, Chavez-Blanco A, et al. Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug. Cancer Chemother Pharmacol 2020;85:1153-1163.
PMID: 32474842